This is a recipe from
PiHKAL. If you're interested in how the hardlinks
were chosen, read
noding PiHKAL for Everything2.
#120 MEDA
3-METHOXY-4,5-ETHYLENEDIOXYAMPHETAMINE
SYNTHESIS: To a
solution of 50 g
3,4-dihydroxy-5-methoxybenzaldehyde
in 100 mL
distilled
acetone there was added 70 g
ethylene bromide and
58 g finely powdered
anhydrous K2CO3. The mixture was held at reflux
for 5 days. This was then poured into 1.5 L H2O and extracted with
4x100 mL
CH2Cl2. Removal of the
solvent from the pooled extracts gave
a residue which was
distilled at 19 mm/
Hg. Several of the fractions
taken in the 203-210 °C range spontaneously
crystallized, and they
were pooled to give 18.3 g of
3-methoxy-4,5-ethylenedioxybenzaldehyde
as white solids with a mp of 80-81 °C. A small sample with an equal
weight of
malononitrile in
EtOH treated with a few drops of
triethylamine gave
3-methoxy-4,5-ethylenedioxybenzalmalononitrile as
pale yellow
crystals from
EtOH with a mp of 153-154 °C.
A
solution of 1.50 g
3-methoxy-4,5-ethylenedioxybenzaldehyde in 6 mL
acetic acid was treated with 1 mL
nitroethane and 0.50 g
anhydrous
ammonium acetate, and held on the steam bath for 1.5 h. To the cooled
mixture H2O was cautiously added until the first permanent turbidity
was observed, and once
crystal-lization had set in, more H2O was added
at a rate that would allow the generation of additional
crystals.
When there was a
residual turbidity from additional H2O, the addition
was stopped, and the beaker held at ice tem
perature for several h.
The product was removed by filtration and washed with a little 50%
acetic acid, providing 0.93 g
1-(3-methoxy-4,5-ethylenedioxyphenyl)-2-nitropropene as dull yellow
crystals with a mp of 116-119 °C. Recrystallization of an
analytical
sample from MeOH gave a mp of 119-121 °C.
A stirred suspension of 6.8 g LAH in 500 mL
anhydrous Et2O under an
inert
atmosphere was brought up to a gentle reflux. A total of 9.4 g
1-(3-methoxy-4,5-ethylenedioxyphenyl)-2-nitropropene in warm
Et2O was
added over the course of 0.5 h.
Refluxing was maintained for 6 h, and
then the reaction mixture was cooled and the excess
hydride destroyed
by the cautious addition of 400 mL 1.5 N H2SO4. The two clear
phases
were separated, and the aqueous
phase was brought to
pH of 6 by the
addition of a saturated
Na2CO3 solution. This was filtered free of a
small amount of in
solubles, and the clear filtrate was heated to 80
°C. To this there was added a
solution of 9.2 g picric acid (90%
material) in 100 mL boiling
EtOH, and the clear mixture allowed to
cool in an ice bath. Scratching generated yellow
crystals of the
picrate salt. This salt was filtered free of the aqueous environment,
treated with 50 mL of 5%
NaOH, and stirred until the picric acid was
totally in the form of the
soluble sodium salt. This was then
extracted with 3x100 mL
CH2Cl2, the extracts pooled, and the
solvent
removed under vacuum. The residue weighed 6.0 g, and was
dissolved in
100 mL
anhydrous Et2O, and saturated with dry HCl gas. The white
solids that formed were filtered free of the
Et2O, and ground up under
50 mL of slightly moist
acetone, providing 4.92 g of
3-methoxy-4,5-ethylenedioxyamphetamine hydrochloride monohydrate
(MEDA) as white
crystals.
DOSAGE: greater than 200 mg.
DURATION: unknown.
EXTENSIONS AND COMMENTARY: There are times when the Gods smile in
unexpectedly nice ways. Having found the activity of M
MDA, the
"scientific" thing to do would be to compare it against the other
"
psychotomimetic"
amphetamine that was known at that time (this was
1962), namely TMA. Comparing their structures, the only difference of
any kind was that two of the adjacent
methoxyl groups of TMA were
replaced with a 5-membered ring, called the
methylenedioxy ring.
Where does one go next? Some perverse inspiration suggested
increasing the size of this ring to a 6-membered ring, the
ethylenedioxy (or
dioxene)
homologue. Well, if you thought that
getting
myristicinaldehyde was a difficulty, it was nothing compared
to getting this 6-membered counterpart. But I huffed and I puffed,
and I did make enough to taste and to evaluate. And it was here that
I got the divine message! No activity!! So, rather than being
condemned forever a la Sisyphus to push ever larger rings up my
psyche, I gave myself permission to pursue another path. The message
was: "Don't change the groups. Leave them as they are, but relocate
them instead." And that led directly to TMA-2 and its story.
A couple of diversions may be mentioned here. Before the blessed
inactivity of MEDA was established, the 7-membered ring counterpart,
3-methoxy-4,5-trimethylenedioxyamphetamine (MTMA) was prepared by
essentially the same procedure. The above
3-methoxy-4,5-dihydroxybenzaldehyde with
trimethylene bromide gave
3-methoxy-4,5-trimethylenedioxybenzaldehyde, white solids, with a
malononitrile derivative with a mp of 134-135 °C; the
aldehyde with
nitroethane gave the
nitropropene with a mp of 86-87 °C; and this with
LAH gave MTDA as the
hydrochloride (mp 160-161 °C) again isolated
first as the picrate. It had been tasted at up to an 8 milligram
dosage (no activity, but none expected) before being abandoned. And,
an initial effort was made to
synthesize a five-member ring
(
methylenedioxy) with a
methyl sticking out from it. This
ethylidine
homologue got as far as the
aldehyde stage. The reaction between
3,4-dihydroxy-5-methoxybenzaldehyde and
1,1-dibromoethane in
acetone
containing
anhydrous potassium carbonate gave a minuscule amount of a
product that was a two-component mixture. This was resolved by dozens
of separate injections into a preparatory gas
chromatography system,
allowing the isolation of the second of the two components in a
quantity sufficient to demonstrate (by
NMR spectroscopy) that it was
the desired
3-methoxy-4,5-ethylidinedioxybenzaldehyde. Starting with
the pre-prepared
dipotassium salt or the lead salt of the
catecholaldehyde gave nothing. With no activity being found with
MEDA, all was abandoned.
There are some comments made under
MDA for successful chemistry (using
a different approach) alo#ng these lines when there is no
methoxyl
group present. These are the compounds EDA and IDA. But the
pharmacology was still not that exciting.
Back to PiHKAL?